Chih-Yang Huang Selected Research

Resveratrol

1/2021	Antioxidant Sirt1/Akt axis expression in resveratrol pretreated adipose-derived stem cells increases regenerative capability in a rat model with cardiomyopathy induced by diabetes mellitus.
5/2020	Resveratrol enhances therapeutic effect on pancreatic regeneration in diabetes mellitus rats receiving autologous transplantation of adipose-derived stem cells.
7/2019	Ramipril and resveratrol co-treatment attenuates RhoA/ROCK pathway-regulated early-stage diabetic nephropathy-associated glomerulosclerosis in streptozotocin-induced diabetic rats.
1/2019	Protective effect of autologous transplantation of resveratrol preconditioned adipose-derived stem cells in the treatment of diabetic liver dysfunction in rat model.
1/2018	Acute hypoxic preconditioning prevents palmitic acid-induced cardiomyocyte apoptosis via switching metabolic GLUT4-glucose pathway back to CD36-fatty acid dependent.
12/2017	A review on the effects of current chemotherapy drugs and natural agents in treating non-small cell lung cancer.
1/2016	Resveratrol attenuated hydrogen peroxide-induced myocardial apoptosis by autophagic flux.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chih-Yang Huang Research Topics

Disease

110	Neoplasms (Cancer) 12/2023 - 09/2005
66	Hypertrophy 09/2022 - 01/2002
65	Cardiomegaly (Heart Hypertrophy) 01/2024 - 11/2004
59	Fibrosis (Cirrhosis) 03/2024 - 10/2005
45	Inflammation (Inflammations) 05/2024 - 05/2006
42	Hypoxia (Hypoxemia) 01/2023 - 01/2007
34	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 09/2005
31	Neoplasm Metastasis (Metastasis) 01/2023 - 09/2006
28	Hypertension (High Blood Pressure) 12/2022 - 01/2004
21	Heart Failure 01/2024 - 05/2006
20	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 10/2009
19	Heart Diseases (Heart Disease) 11/2023 - 10/2005
18	Cardiomyopathies (Cardiomyopathy) 03/2024 - 01/2011
18	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 04/2006
16	Colonic Neoplasms (Colon Cancer) 01/2024 - 04/2006
15	Body Weight (Weight, Body) 07/2022 - 10/2005
14	Cardiotoxicity 12/2023 - 09/2016
13	Obesity 12/2021 - 10/2007
12	Carcinogenesis 12/2019 - 05/2007
11	Mitochondrial Diseases (Mitochondrial Disease) 12/2023 - 01/2013
11	Mouth Neoplasms (Oral Cancer) 01/2023 - 12/2007
10	Diabetic Cardiomyopathies 03/2024 - 01/2011
10	Lung Neoplasms (Lung Cancer) 12/2023 - 05/2008
10	Hyperglycemia 03/2023 - 09/2015
10	Squamous Cell Carcinoma of Head and Neck 06/2019 - 11/2009
9	Breast Neoplasms (Breast Cancer) 01/2023 - 06/2004
9	Myocardial Infarction 06/2019 - 12/2007
8	Ischemia 12/2023 - 06/2010
8	Wounds and Injuries (Trauma) 12/2023 - 01/2016
8	Necrosis 03/2023 - 03/2007
8	Hyperlipidemias (Hyperlipidemia) 01/2023 - 06/2011
8	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 05/2011
7	Parkinson Disease (Parkinson's Disease) 01/2023 - 03/2013
7	Diabetes Mellitus 01/2021 - 02/2014
7	Osteosarcoma (Osteogenic Sarcoma) 05/2020 - 04/2005
6	Adenocarcinoma of Lung 12/2023 - 05/2008

Drug/Important Bio-Agent (IBA)

97	Proteins (Proteins, Gene)FDA Link 12/2023 - 02/2002
23	Matrix Metalloproteinases (MMPs)IBA 11/2023 - 06/2004
22	Atrial Natriuretic Factor (ANF)IBA 07/2022 - 11/2004
22	Insulin-Like Growth Factor II (Somatomedin A)IBA 12/2021 - 01/2002
21	CalcineurinIBA 07/2022 - 12/2005
21	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 07/2008
20	Angiotensin IIIBA 12/2022 - 07/2006
18	Insulin-Like PeptidesIBA 12/2023 - 01/2002
17	AntioxidantsIBA 12/2023 - 02/2010
17	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2023 - 09/2016
17	CollagenIBA 11/2022 - 01/2011
16	Estrogen ReceptorsIBA 09/2023 - 07/2006
15	Insulin-Like Growth Factor I (IGF-1)IBA 11/2023 - 02/2002
14	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2022 - 05/2008
13	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024 - 11/2014
12	Caspase 3 (Caspase-3)IBA 09/2022 - 04/2008
12	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 02/2007
11	IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)IBA 09/2023 - 07/2006
11	Estrogens (Estrogen)FDA Link 01/2023 - 09/2006
11	CholesterolIBA 09/2022 - 12/2007
11	EnzymesIBA 08/2022 - 06/2004
11	Phosphotransferases (Kinase)IBA 12/2021 - 05/2009
11	CateninsIBA 09/2019 - 08/2011
11	Messenger RNA (mRNA)IBA 07/2017 - 08/2006
10	Sirtuin 1IBA 12/2023 - 01/2018
9	Therapeutic UsesIBA 03/2024 - 01/2012
9	Transcription Factors (Transcription Factor)IBA 11/2022 - 06/2008
9	neferineIBA 07/2022 - 12/2015
9	Arecoline (Arecolin)IBA 02/2022 - 04/2013
9	Mitogen-Activated Protein KinasesIBA 02/2022 - 04/2005
9	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2022 - 05/2008
9	Streptozocin (Streptozotocin)FDA Link 09/2021 - 01/2011
9	Death Domain ReceptorsIBA 08/2021 - 10/2005
9	Insulin (Novolin)FDA Link 01/2021 - 06/2002
8	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2024 - 01/2018
8	Interleukin-6 (Interleukin 6)IBA 11/2023 - 12/2010
8	CytokinesIBA 08/2023 - 05/2009
8	LipidsIBA 01/2023 - 04/2006
8	Antineoplastic Agents (Antineoplastics)IBA 12/2022 - 04/2014
8	Protein Kinases (Protein Kinase)IBA 02/2022 - 04/2005
8	Caspase 8 (Caspase-8)IBA 01/2022 - 04/2008
8	transcription factor NF-AT c3IBA 09/2021 - 08/2012
8	p38 Mitogen-Activated Protein KinasesIBA 09/2019 - 03/2007
7	TeaIBA 03/2024 - 03/2014
7	MicroRNAs (MicroRNA)IBA 12/2023 - 01/2018
7	Biomarkers (Surrogate Marker)IBA 11/2023 - 02/2009
7	Caspase 9IBA 09/2022 - 08/2006
7	Advanced Glycation End ProductsIBA 08/2022 - 08/2017
7	ResveratrolIBA 01/2021 - 01/2016
7	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2019 - 12/2005
7	Protein Kinase C-alphaIBA 09/2016 - 09/2005
6	Irinotecan (Camptosar)FDA LinkGeneric 12/2023 - 07/2014
6	fisetinIBA 09/2023 - 01/2018
6	oxidized low density lipoproteinIBA 09/2022 - 12/2007
6	Protein Kinase CIBA 02/2022 - 09/2005
6	Hematoxylin (Haematoxylon)IBA 01/2022 - 10/2007
6	Eosine Yellowish-(YS) (Eosin)IBA 01/2022 - 10/2007
6	Histone Deacetylase InhibitorsIBA 01/2022 - 01/2014
6	LigandsIBA 12/2021 - 04/2006

Therapy/Procedure

44	Therapeutics 12/2023 - 04/2006
17	Drug Therapy (Chemotherapy) 12/2023 - 02/2012
11	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2023 - 10/2009
8	Oral Administration 07/2021 - 02/2010
7	Transplantation 08/2023 - 11/2017